TALEN

TALEN1-doc2a

ID

ZDB-TALEN-180228-1

Name

TALEN1-doc2a

Previous Names

None

Target

doc2a (1)

Target Sequence 1

5' - CTCCATCCAGGAACA - 3'

Target Sequence 2

5' - ATGGGGCCCGGACAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
wi721	doc2a

Expression

Gene expression in Wild Types + TALEN1-doc2a

No data available

Phenotype

Phenotype resulting from TALEN1-doc2a

No data available

Phenotype of all Fish created by or utilizing TALEN1-doc2a

Phenotype	Fish	Conditions	Figures
eye increased height, abnormal	doc2a^wi721/wi721	standard conditions	Fig. 5 from McCammon et al., 2017
eye decreased distance eye, abnormal	doc2a^wi721/wi721	standard conditions	Fig. 5 from McCammon et al., 2017
hindbrain increased width, abnormal	doc2a^wi721/wi721	standard conditions	Fig. 5 from McCammon et al., 2017
whole organism increased size, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Table 1 from McCammon et al., 2017
whole organism velocity, ameliorated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol, chemical treatment: carbamazepine	Fig. S4 from McCammon et al., 2017
swimming behavior rate, ameliorated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol, chemical treatment: valproic acid	Fig. S4 from McCammon et al., 2017
head increased height, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Fig. 5 from McCammon et al., 2017
swimming behavior increased rate, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	control	Fig. 3 from McCammon et al., 2017
eye increased height, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Fig. 5 from McCammon et al., 2017
swimming behavior rate, ameliorated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol, chemical treatment: carbamazepine	Fig. S4 from McCammon et al., 2017
whole organism increased length, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Fig. 4 from McCammon et al., 2017
whole organism velocity, ameliorated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol, chemical treatment: valproic acid	Fig. S4 from McCammon et al., 2017
whole organism behavioural activity, ameliorated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol, chemical treatment: valproic acid	Fig. S4 from McCammon et al., 2017
head increased size, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Table 1 from McCammon et al., 2017
whole organism increased velocity, exacerbated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol	Fig. 3 from McCammon et al., 2017
whole organism lipid increased amount, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Table 1 from McCammon et al., 2017
whole organism increased velocity, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Fig. 3, Table 1 from McCammon et al., 2017
whole organism increased behavioural activity, exacerbated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol	Fig. 3 from McCammon et al., 2017
forebrain increased width, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Fig. 5 from McCammon et al., 2017
whole organism behavioural activity, ameliorated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol, chemical treatment: carbamazepine	Fig. S4 from McCammon et al., 2017
whole organism increased behavioural activity, abnormal	doc2a^wi721/+; tlcd3ba^wi720/+	standard conditions	Fig. 3, Table 1 from McCammon et al., 2017
swimming behavior rate, exacerbated	doc2a^wi721/+; tlcd3ba^wi720/+	chemical treatment: pentetrazol	Fig. 3 from McCammon et al., 2017

Citations